Ibio Reconciled Depreciation vs Gross Profit Analysis
IBIO Stock | USD 1.98 0.17 9.39% |
Ibio financial indicator trend analysis is infinitely more than just investigating Ibio Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ibio Inc is a good investment. Please check the relationship between Ibio Reconciled Depreciation and its Gross Profit accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
Reconciled Depreciation vs Gross Profit
Reconciled Depreciation vs Gross Profit Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ibio Inc Reconciled Depreciation account and Gross Profit. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Ibio's Reconciled Depreciation and Gross Profit is 0.46. Overlapping area represents the amount of variation of Reconciled Depreciation that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Ibio Inc, assuming nothing else is changed. The correlation between historical values of Ibio's Reconciled Depreciation and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Reconciled Depreciation of Ibio Inc are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Reconciled Depreciation i.e., Ibio's Reconciled Depreciation and Gross Profit go up and down completely randomly.
Correlation Coefficient | 0.46 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Reconciled Depreciation
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Ibio Inc minus its cost of goods sold. It is profit before Ibio operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most indicators from Ibio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ibio Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. As of the 18th of May 2024, Selling General Administrative is likely to drop to about 11 M. In addition to that, Discontinued Operations is likely to drop to about (33.7 M)
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 2.2M | 50K | 57.5K | 54.6K | Total Revenue | 2.4M | 50K | 57.5K | 54.6K |
Ibio fundamental ratios Correlations
Click cells to compare fundamentals
Ibio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ibio fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 94.2M | 147.0M | 99.4M | 41.2M | 47.4M | 39.2M | |
Other Current Liab | 1.1M | 3.0M | 3.8M | 1.9M | 2.2M | 1.6M | |
Total Current Liabilities | 5.2M | 6.6M | 30.4M | 21.6M | 24.8M | 26.1M | |
Total Stockholder Equity | 56.6M | 108.6M | 63.5M | 15.4M | 17.7M | 19.8M | |
Property Plant And Equipment Net | 31.3M | 34.7M | 41.8M | 7.6M | 8.7M | 14.0M | |
Net Debt | (22.2M) | (44.7M) | 5.1M | 12.8M | 11.5M | 12.1M | |
Retained Earnings | (150.4M) | (173.6M) | (223.9M) | (288.9M) | (260.0M) | (247.0M) | |
Accounts Payable | 1.8M | 2.3M | 4.3M | 1.8M | 2.1M | 1.7M | |
Cash | 55.1M | 77.4M | 22.7M | 4.3M | 4.9M | 4.7M | |
Non Current Assets Total | 32.4M | 42.4M | 54.3M | 14.9M | 17.2M | 18.1M | |
Cash And Short Term Investments | 55.1M | 97.0M | 33.5M | 4.3M | 4.9M | 4.7M | |
Net Receivables | 5.6M | 5.5M | 6.1M | 204K | 234.6K | 222.9K | |
Common Stock Shares Outstanding | 125.6K | 391.2K | 17.4K | 612.3K | 704.1K | 739.3K | |
Liabilities And Stockholders Equity | 94.2M | 147.0M | 99.4M | 41.2M | 47.4M | 39.2M | |
Non Current Liabilities Total | 32.3M | 31.8M | 5.5M | 4.2M | 3.8M | 3.6M | |
Other Current Assets | 214K | 2.1M | (82K) | 664K | 763.6K | 801.8K | |
Other Stockholder Equity | 206.9M | 282.1M | 287.6M | 304.3M | 349.9M | 367.4M | |
Total Liab | 37.6M | 38.4M | 35.9M | 25.8M | 29.7M | 18.5M | |
Property Plant And Equipment Gross | 31.3M | 34.7M | 45.3M | 8.2M | 9.4M | 14.3M | |
Total Current Assets | 61.7M | 104.6M | 45.1M | 26.3M | 30.2M | 21.1M | |
Intangible Assets | 1.1M | 952K | 4.9M | 5.4M | 4.8M | 5.1M | |
Common Stock | 16K | 20K | 140K | 217K | 9K | 21.9K | |
Property Plant Equipment | 3.7M | 34.7M | 41.8M | 7.6M | 8.7M | 13.8M | |
Common Stock Total Equity | 16K | 20K | 140K | 217K | 249.6K | 262.0K | |
Inventory | 798K | 27K | 3.9M | 21.1M | 24.3M | 25.5M | |
Net Tangible Assets | 56.6M | 107.6M | 58.6M | 10.0M | 11.5M | 10.9M | |
Short Term Debt | 562K | 967K | 22.3M | 13.6M | 15.6M | 16.4M | |
Accumulated Other Comprehensive Income | (31K) | (33K) | (63K) | (213K) | (191.7K) | (182.1K) | |
Short Long Term Debt Total | 32.9M | 32.7M | 27.8M | 17.1M | 15.4M | 21.1M | |
Current Deferred Revenue | 1.8M | 423K | 100K | 4.2M | 4.8M | 5.1M | |
Capital Lease Obligations | 32.3M | 32.1M | 5.6M | 4.1M | 3.7M | 3.5M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Ibio Stock analysis
When running Ibio's price analysis, check to measure Ibio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ibio is operating at the current time. Most of Ibio's value examination focuses on studying past and present price action to predict the probability of Ibio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ibio's price. Additionally, you may evaluate how the addition of Ibio to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Ibio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ibio. If investors know Ibio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ibio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (15.25) | Revenue Per Share 0.044 | Quarterly Revenue Growth (0.88) | Return On Assets (0.30) | Return On Equity (1.48) |
The market value of Ibio Inc is measured differently than its book value, which is the value of Ibio that is recorded on the company's balance sheet. Investors also form their own opinion of Ibio's value that differs from its market value or its book value, called intrinsic value, which is Ibio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ibio's market value can be influenced by many factors that don't directly affect Ibio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ibio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ibio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ibio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.